Michael Kaplan

Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…

Davis Polk advised the representatives of the several underwriters in connection with the $995.6 million secondary offering of 22.25 million shares of common stock of Hilton Grand…

Davis Polk is advising the lead arranger in connection with (i) the $1.64 billion senior secured credit facilities being provided to Altra Industrial Motion Corp. and (ii) the $400…

Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $325 million principal amount of senior notes due 2026 of WMG…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 4,255,000 shares of common stock of NMI…

Davis Polk is advising Comcast Corporation in connection with its £22.1 billion ($30.8 billion) possible cash offer to acquire the entire share capital of Sky plc. Under the terms of…

Davis Polk advised the representatives of the underwriters in connection with Gates Industrial Corporation plc’s initial public offering of 38,500,000 ordinary shares, at $19.00 per share,…

Davis Polk advised the representatives of the several underwriters, in an SEC-registered offering by Ensco plc of $1 billion aggregate principal amount of its 7.75% senior notes due…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S reopening by Hologic, Inc. of $600 million aggregate principal amount of its 4…

Davis Polk advised the financial adviser to GNC Holdings, Inc. in connection with the company’s offer to certain existing holders of its outstanding 1.50% convertible senior notes due 2020 …